Pfizer oncology head Liz Barrett jumps ship to Novartis as Bruno Strigini steps aside
Novartis $NVS has found a successor to outgoing oncology chief Bruno Strigini — at Pfizer. Liz Barrett, current global president of oncology at Pfizer, has been tapped to run the show at Novartis.
Barrett has big shoes to fill. The Swiss drugmaker has taken up a large presence in cancer since hiring Strigini — who’s says he’s retiring from the industry altogether — from a senior Merck position in the summer of 2014. Particularly memorable are its role in spearheading the first CAR-T to hit the market and the integration of GSK’s oncology portfolio.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.